NICE recommends Pharmalgen as a possible treatment for some people with bee or wasp venom allergy (see below).
Who can have Pharmalgen?
You should be able to have Pharmalgen if:
- you have had a severe reaction to a bee or wasp sting, or
- you have had a moderate reaction to a bee or wasp sting and you have one or more of the following: a high risk of stings, anxiety about stings, raised levels of a protein called ‘tryptase’ in your blood.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended Pharmalgen because, although it costs more than other treatments, this was justified by the benefits it provided.
The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Commissioners and/or providers have a responsibility to provide the funding required to enable the guidance to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.